DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma
DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma
Recruiting · NCT07110038 · Registry updated 2026-06-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma | Penile Squamous Cell Carcinoma (PSCC) | Recruiting | Phase 2 | 2026-06-22 | NCT07110038 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Caritas St. Josef Medical Center | Regensburg | Germany | 1 |
| Rostock University Medical Center | Rostock | Germany | 3 |
| Technical University of Munich, University Hospital Munich | Munich | Germany | 1 |
| University Hospital and Medical Faculty, Heinrich-Heine-University, Düsseldorf | Düsseldorf | Germany | 1 |
| University Hospital Mannheim | Mannheim | Germany | 1 |
| University Hospital Tübingen | Tübingen | Germany | 12 |
| University Medical Center of Johannes Gutenberg-University | Mainz | Germany | 2 |
| Universitätsklinikum Carl Gustav Carus | Dresden | Germany | 3 |